Combining her training in genetics (PhD, University of Sydney) and law (Juris Doctor, 2003 Gold medalist, University of Alberta), and her experience as an assistant professor at the School of Business, University of Alberta (2004-2008), Dr. Tania Bubela is an expert in health and intellectual property law and policy. She is the Dean of the Faculty of Health Sciences at Simon Fraser University, and is leading the development of policies, processes, practices and infrastructure to support excellence in interdisciplinary education, research, and engagement that will improve health, health equity, and well-being.
Dr. Bubela’s research interests include intellectual property law and policy, health law, genomics, technology transfer, commercialization of biomedical research and science communication. In addition to being the Lead for the Precision Medicine Policy Networks’ Intellectual Property and Commercialization theme, Dr. Bubela co-leads the Genome Canada PACEOMICS project and the Alberta Ocular Gene Therapy Team (CRIO-AI). She also leads a project on the enablers and barriers for personalized cancer biotherapies in Canada.